The clinical features of malignant hyperpyrexia (MH) and the observed hypercontractility of isolated MH-susceptible (MHS) skeletal muscle fibres to certain chemical stimuli indicate a dysfunction in the processes which regulate myoplasmic Ca2+ concentration [1]. While the precise site of the lesion which predisposes to the abnormally high Ca2+ concentration is unknown, events of excitation—contraction coupling and Ca2+ transport by the sarcoplasmic reticulum (SR) have been implicated [2,3]. In skeletal muscle, voltage-dependent Ca2+ currents flow almost exclusively across the trans-verse tubular (T-tubular) membrane and are blocked by calcium channel antagonists [4]. Calcium channel antagonist receptors are localized preferentially at the T...
Malignant hyperthermia (MH) is a potentially fatal, inherited skeletal muscle disorder in humans and...
Item does not contain fulltextChanges in intracellular Ca2+-concentration play an important role in ...
AbstractCalcium-induced calcium release and halothane-induced calcium release from pig sarcoplasmic ...
Malignant hyperthermia (MH) is a pharmacogenetic disorder most often linked to mutations in the type...
Dantrolene is the drug of choice for the treatment of malignant hyperthermia (MH) and is also useful...
AbstractCalcium pulse additions to isolated SR membranes can cause a reversible efflux of calcium. T...
In vitro studies, using agents which act specifically on different parts of the muscle contractile m...
Malignant hyperthermia (MH) is a clinical syndrome of skeletal muscle that presents as a hypermetabo...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Summary Human malignant hyperthermia is a life-threatening genetic sensitivity of skeletal muscles t...
Abstract[3H]PN 200-110, a potent chiral benzoxadiazol 1,4-dihydropyridine Ca2+ antagonist was used t...
Malignant hyperthermia (MH) is a potentially fatal pharmacogenetic disorder of skeletal muscle that ...
Malignant hyperthermia (MH) is a pharmacogenetic disease of humans and various animal species that p...
The lack of dystrophin in mdx mice and in Duchenne muscular dystrophy causes sarcolemmal breakdown a...
The lack of dystrophin in mdx mice and in Duchenne muscular dystrophy causes sarcolemmal breakdown a...
Malignant hyperthermia (MH) is a potentially fatal, inherited skeletal muscle disorder in humans and...
Item does not contain fulltextChanges in intracellular Ca2+-concentration play an important role in ...
AbstractCalcium-induced calcium release and halothane-induced calcium release from pig sarcoplasmic ...
Malignant hyperthermia (MH) is a pharmacogenetic disorder most often linked to mutations in the type...
Dantrolene is the drug of choice for the treatment of malignant hyperthermia (MH) and is also useful...
AbstractCalcium pulse additions to isolated SR membranes can cause a reversible efflux of calcium. T...
In vitro studies, using agents which act specifically on different parts of the muscle contractile m...
Malignant hyperthermia (MH) is a clinical syndrome of skeletal muscle that presents as a hypermetabo...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Summary Human malignant hyperthermia is a life-threatening genetic sensitivity of skeletal muscles t...
Abstract[3H]PN 200-110, a potent chiral benzoxadiazol 1,4-dihydropyridine Ca2+ antagonist was used t...
Malignant hyperthermia (MH) is a potentially fatal pharmacogenetic disorder of skeletal muscle that ...
Malignant hyperthermia (MH) is a pharmacogenetic disease of humans and various animal species that p...
The lack of dystrophin in mdx mice and in Duchenne muscular dystrophy causes sarcolemmal breakdown a...
The lack of dystrophin in mdx mice and in Duchenne muscular dystrophy causes sarcolemmal breakdown a...
Malignant hyperthermia (MH) is a potentially fatal, inherited skeletal muscle disorder in humans and...
Item does not contain fulltextChanges in intracellular Ca2+-concentration play an important role in ...
AbstractCalcium-induced calcium release and halothane-induced calcium release from pig sarcoplasmic ...